← Back to headlines
Tonix Pharmaceuticals Stock Rises on Medicare Payer Deal for Fibromyalgia Drug
Tonix Pharmaceuticals saw its stock increase following a Medicare payer deal for its fibromyalgia drug, indicating positive market reception for the treatment.
13 Jul, 11:55 — 13 Jul, 11:55
Sources
Showing 1 of 1 sources
